SELLAS Life Sciences Group, Inc. SLS Operating Lease Liabilities (Current)
Operating Lease Liabilities (Current) at other companies
Other financials
Where this comes from
Reported directly by SELLAS Life Sciences Group, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.
The official record: SELLAS Life Sciences Group, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about SELLAS Life Sciences Group, Inc.'s operating lease liabilities (current).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is SELLAS Life Sciences Group, Inc.'s operating lease liabilities (current)?
- SELLAS Life Sciences Group, Inc. (SLS) reported operating lease liabilities (current) of $562K in Q1 2026.
- How has SELLAS Life Sciences Group, Inc.'s operating lease liabilities (current) changed year-over-year?
- SELLAS Life Sciences Group, Inc.'s operating lease liabilities (current) increased by 0.2% year-over-year, from $561K to $562K.
- What is the long-term trend for SELLAS Life Sciences Group, Inc.'s operating lease liabilities (current)?
- Over 5 years (2020 to 2025), SELLAS Life Sciences Group, Inc.'s operating lease liabilities (current) has grown at a 26.8% compound annual growth rate (CAGR), from $166K to $544K.
- What does operating lease liabilities (current) mean?
- The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.